0000885590-15-000026.txt : 20150421 0000885590-15-000026.hdr.sgml : 20150421 20150421174655 ACCESSION NUMBER: 0000885590-15-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150417 FILED AS OF DATE: 20150421 DATE AS OF CHANGE: 20150421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kornwasser Laizer CENTRAL INDEX KEY: 0001387813 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 15783992 MAIL ADDRESS: STREET 1: 100 PARSONS POND DRIVE CITY: FRANKLIN LAKES STATE: NJ ZIP: 07417 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2015-04-17 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001387813 Kornwasser Laizer 2150 ST. ELZEAR BLVD. WEST LAVAL A8 H7L 4A8 QUEBEC, CANADA 0 1 0 0 EVP, Company Group Chairman Common Stock, no par value 2015-04-17 4 M 0 45000 0 A 123377 D Common Stock, no par value 2015-04-17 4 F 0 23337 0 D 100040 D Restricted Share Units 2015-04-17 4 M 0 45000 0 D Common Stock 45000 0 D Each performance-based Restricted Share Unit ("RSU") represents a contingent right to receive between zero and three common shares, no par value ("Common Shares"), of Valeant Pharmaceuticals International, Inc. ("Valeant"), subject to performance based vesting criteria. See note (2). These RSUs were initially eligible to vest based on total shareholder return (TSR) between a price of $63.86 starting on February 1, 2013 and the average stock price for the 20 trading days starting on each measurement dates: 25% on November 1, 2015, 50% on February 1, 2016 and 25% on May 1, 2016, contingent on TSR performance between 10% and 30% into between one and three Common Shares of common stock, respectively, with early vesting possible at higher TSR levels. These performance-based RSUs have now vested in full. This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based RSUs. by: Nicholas Zanoni for Laizer Kornwasser 2015-04-17